These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6669877)

  • 21. [Our experience with "supertransfusive" treatment of homozygous beta-thalassemia].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1983; 91(1):27-30. PubMed ID: 6889088
    [No Abstract]   [Full Text] [Related]  

  • 22. [Transfusion therapy and height-weight and psychic growth in the thalassemic child].
    Braito A; Rondinella I
    Minerva Pediatr; 1965 Sep; 17(25):1330-2. PubMed ID: 5850281
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum IgE in polytransfused thalassemic patients.
    La Rosa M; Pavone L; Musumeci S; Mollica F; Ronchetti R
    Vox Sang; 1983; 45(5):384-8. PubMed ID: 6636660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fetal hemoglobin in the follow-up of homozygous beta-thalassemia in blood transfusion treatment].
    Ferrara M; Ponte G; Esposito L
    Pediatria (Napoli); 1980 Dec; 88(4):541-8. PubMed ID: 6170042
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypertension, convulsive crises and coma in patients with thalassemia major following multiple blood transfusions].
    Bezzi TM; Trombini R; Bergamini M; Banin P
    Minerva Pediatr; 1982 May; 34(9):371-3. PubMed ID: 7121432
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunologic and virologic status of multitransfused thalassemic patients.
    Hwang KC; Hsieh KH; Chen BW; Lin KH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Feb; 23(1):19-26. PubMed ID: 2168312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte antibodies in thalassemic patients.
    Sujirachato K; Chiewsilp P; Isarangkura P
    Birth Defects Orig Artic Ser; 1988; 23(5B):283-5. PubMed ID: 3390553
    [No Abstract]   [Full Text] [Related]  

  • 28. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.
    Bradai M; Pissard S; Abad MT; Dechartres A; Ribeil JA; Landais P; de Montalembert M
    Transfusion; 2007 Oct; 47(10):1830-6. PubMed ID: 17880608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E.
    Das N; Das Chowdhury T; Chattopadhyay A; Datta AG
    Pol J Pharmacol; 2004; 56(1):85-96. PubMed ID: 15047982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension after multiple transfusions.
    Untario S; Netty RH; Permono B
    Paediatr Indones; 1982; 22(7-8):147-51. PubMed ID: 7162835
    [No Abstract]   [Full Text] [Related]  

  • 32. Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran.
    Tamaddoni A; Mohammadzadeh I; Ziaei O
    Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):41. PubMed ID: 17303929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frozen red blood cell transfusion in patients with Cooley's disease.
    Avanzi G; Bacigalupo A; Strada P; Melevendi C; Traverso T; Adami R; Soldà AM; Reali G
    Haematologica; 1983; 68(5):646-55. PubMed ID: 6416942
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum lipids and their modifications after blood transfusion in polytransfused beta-thalassemic patients.
    Leonardi S; Colianni R; Fischer A; Curreri R; Di Gregorio F; Pizzarelli G; Musumeci S
    Haematologica; 1988; 73(4):269-71. PubMed ID: 3139529
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
    [No Abstract]   [Full Text] [Related]  

  • 36. Acquired immunodeficiency syndrome in a thalassemic child.
    Paul R; Dobkin D; Maurer H; Noah Z; Yogev R
    Pediatr Infect Dis; 1986; 5(2):274-6. PubMed ID: 3952016
    [No Abstract]   [Full Text] [Related]  

  • 37. [Height-weight growth in homozygous beta-thalassemia in relation to transfusional regime].
    Miniero R; Sacchetti L; Isolato V
    Minerva Pediatr; 1977 Jan; 29(1):73-80. PubMed ID: 840203
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the behavior, before and after transfusion, of the plasmatic antigens of leukocytic origin in polytransfused thalassemic children].
    Varone D; Vierucci A; Borgatti L; Dettori M
    Riv Emoter Immunoematol; 1965; 12(5):132-8. PubMed ID: 4958387
    [No Abstract]   [Full Text] [Related]  

  • 39. Transfusion-related immunologic abnormalities in beta-thalassemia major.
    Grady RW; Akbar AN; de Sousa M; Giardina PJ; Hilgartner MW
    Birth Defects Orig Artic Ser; 1987; 23(5A):587-93. PubMed ID: 3689945
    [No Abstract]   [Full Text] [Related]  

  • 40. Transfusion associated hepatitis C in multi-transfused thalassemic children.
    Mishra D; Pensi T
    Indian Pediatr; 2004 Mar; 41(3):287-8. PubMed ID: 15064522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.